Clinical Research Directory

Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users

Sponsor: Bristol-Myers Squibb

Summary

This study uses existing health records and insurance claims data to understand how adults in the United States are treated with KarXT, a medication for schizophrenia. It will describe who receives KarXT, how it is used in real-world practice, and how often healthcare services such as hospital visits are used. It will also explore information recorded by clinicians about schizophrenia symptoms

Official title: The Current Landscape of Cobenfy (KarXT): Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization

Key Details

Conditions

Interventions

Locations (1)